academic labs
action
applications
book
Category=PN
Category=PSAK
Category=PSAX
emerging
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
extensively
gene
general
industry
interference
mechanisms
molecules
novice
overview
pharmaceutical
rapidly
reader today
rna
target
therapeutics
unfamiliar
Product details
- ISBN 9780471771517
- Weight: 590g
- Dimensions: 160 x 239mm
- Publication Date: 28 Jan 2011
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.
